← Eichor
Condition: Sglt 2 Inhibitor Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sglt 2 Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients
Phase N/A · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07237451Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment
Phase 3 · 9 location(s) · Christian Schulze · NCT07038356Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
NA · 1 location(s) · Oman Ministry of Health · NCT07491042Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Canc
Phase 1 · 1 location(s) · West China Hospital · NCT07076823SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning
Phase 3 · 1 location(s) · National Taiwan University Hospital · NCT06142474Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
Phase 2 · 17 location(s) · University of Dundee · NCT06435156Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary
Phase 4 · 1 location(s) · The University of Hong Kong · NCT06668389Dapagliflozin for Cardio-renal Protection After ICU Discharge
Phase 3 · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07025629SGLT2i, Pioglitazone, and Ketone Production in T1D
Phase 3 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT07056699Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Phase 2 · 1 location(s) · Alexandria University · NCT06845163Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
Phase 4 · 2 location(s) · China National Center for Cardiovascular Diseases · NCT06055452The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Phase 4 · 2 location(s) · The University of Hong Kong · NCT07482943Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
Phase 2 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06913647Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)
NA · 1 location(s) · National Health Research Institutes, Taiwan · NCT06271200Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Phase 1 · 1 location(s) · McGill University · NCT06753994Mechanism of SGLT2 Inhibition in the Kidney
Phase 4 · 1 location(s) · University of Michigan · NCT06291155Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Phase 2 · 1 location(s) · University of Edinburgh · NCT06887062SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
Phase 4 · 1 location(s) · Odense University Hospital · NCT07143773Metabolic Response to the Initiation of Heart Failure Therapy
Phase N/A · 1 location(s) · Vojtech Melenovsky, MD, PhD · NCT06283420Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Phase 3 · 19 location(s) · Alessandro Doria · NCT06217302Effect of Empagliflozin on Inflammation
Phase 4 · 1 location(s) · Hotel Dieu de France Hospital · NCT07292909Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inade
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06863532SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Phase 3 · 8 location(s) · Region Örebro County · NCT05852704Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Phase 2 · 1 location(s) · Abdelrahman Mahmoud · NCT07336797Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Inf
Phase 4 · 1 location(s) · Samsung Medical Center · NCT04899479SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose M
Phase 2 · 1 location(s) · Huashan Hospital · NCT07482020Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting
Phase N/A · 1 location(s) · Pyatigorsk City Clinical Hospital Number 1 · NCT07601867Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Phase 2 · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT07018622Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left
Phase 3 · 8 location(s) · Central Hospital, Nancy, France · NCT05879276
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.